News - MedTech

BenevolentAI’s new CEO reports restructured firm’s 2023 results

BenevolentAI's new CEO Dr Joerg Moeller has reported the company's 2023 results. The London-headq...

Phagenesis raises £33m in Series D funding round

Manchester-based Phagenesis has raised £33 million in a Series D funding round. The medical devi...

Hunt makes £360m manufacturing, R&D pledge ahead of Budget

Chancellor Jeremy Hunt has announced a ‘significant’ investment package in the UK’s life scien...

MedTech 50 firm TrakCel expands partner ecosystem

TrakCel is expanding its OCELLOS partner ecosystem, which will bring the total number of integrated ...

Cancer-fighting BioTech Curve raises £40.5m

Curve Therapeutics has raised £40.5 million in Series A financing to develop breakthrough cancer tr...

NATROX® O₂ ‘helps repair tissue post-Mohs surgery’

NATROX® O₂, a continuous topical oxygen therapy, is gaining attention for its potential role in m...

Preparing alginate: manual, semi-automatic or automatic mixing?

Alginate is the most commonly-used impression material for fabricating study models, creating antago...

Spinout develops treatment for diabetics at risk of amputation

IsomAb - a University of Nottingham spinout pioneering a new treatment for diabetics at risk of ampu...

MIP Discovery raises £7m to advance cell and gene therapies

MIP Discovery, an innovative developer of non-biological affinity reagents designed to accelerate th...

‘World-first’ soft prosthetics startup Koalaa raises close to £1m

London prosthetics startup Koalaa has closed a funding round of £925,000. Its ‘world-first’ ...

Fresh funding for lab models that replace animal testing

Newcells Biotech - whose laboratory models are used in drug development and reduce reliance on anima...

Former chair provides lifeline to listed MedTech TruSpine

Listed MedTech TruSpine has secured a temporary lifeline in the form of a loan from former chairman ...

Subscribe to our newsletter

    This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.